These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. Measurement of paraoxonase (PON1) status as a potential biomarker of susceptibility to organophosphate toxicity. Costa LG, Cole TB, Vitalone A, Furlong CE. Clin Chim Acta; 2005 Feb 30; 352(1-2):37-47. PubMed ID: 15653099 [Abstract] [Full Text] [Related]
16. Serum paraoxonase status: a major factor in determining resistance to organophosphates. Li WF, Costa LG, Furlong CE. J Toxicol Environ Health; 1993 Feb 30; 40(2-3):337-46. PubMed ID: 7693961 [Abstract] [Full Text] [Related]
17. The toxicity of mixtures of specific organophosphate compounds is modulated by paraoxonase 1 status. Cole TB, Jansen K, Park S, Li WF, Furlong CE, Costa LG. Adv Exp Med Biol; 2010 Feb 30; 660():47-60. PubMed ID: 20221870 [Abstract] [Full Text] [Related]
19. PON1 status of farmworker mothers and children as a predictor of organophosphate sensitivity. Furlong CE, Holland N, Richter RJ, Bradman A, Ho A, Eskenazi B. Pharmacogenet Genomics; 2006 Mar 30; 16(3):183-90. PubMed ID: 16495777 [Abstract] [Full Text] [Related]
20. Low paraoxonase in Persian Gulf War Veterans self-reporting Gulf War Syndrome. Mackness B, Durrington PN, Mackness MI. Biochem Biophys Res Commun; 2000 Sep 24; 276(2):729-33. PubMed ID: 11027539 [Abstract] [Full Text] [Related] Page: [Next] [New Search]